HKEX:2563

Beijing Biostar Pharmaceuticals . Stock Forecast

etoro logo Buy 2563
*Your capital is at risk
HK$3.50
-0.0400 (-1.13%)
At Close: Aug 11, 2026

Should you buy 2563.HK stock?

Last updated:

Based on market data through , StockInvest.us rates Beijing Biostar Pharmaceuticals Co., Ltd. (2563.HK) as a Sell Candidate with a technical score of -3.99 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Sell signal since
  • Price since signal Flat 0.00%
  • 3-month trend forecast Down 17.22%
  • Sell Candidate -3.99
AI Analysis AI Analysis of 2563.HK AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add 2563 to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Red day on Tuesday for Beijing Biostar Pharmaceuticals Co.,
(Market data through Aug 11, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Aug 04, 2026

The Beijing Biostar Pharmaceuticals Co., stock price fell by -1.13% on the last day (Tuesday, 11th Aug 2026) from HK$3.54 to HK$3.50. During the last trading day the stock fluctuated 0.143% from a day low at HK$3.50 to a day high of HK$3.51. The price has fallen in 4 of the last 10 days and is down by -1.41% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -2 thousand shares and in total, 1 thousand shares were bought and sold for approximately HK$3.50 thousand.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at HK$3.58 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -17.22% during the next 3 months and, with a 90% probability hold a price between HK$1.75 and HK$2.97 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

2563.HK Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Beijing Biostar Pharmaceuticals Co., stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at HK$3.51 and HK$3.58. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -9.33%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Beijing Biostar Pharmaceuticals Co., stock

Beijing Biostar Pharmaceuticals Co., finds support from accumulated volume at HK$3.39 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have controlled movements and therefore the general risk is considered low. However, be aware of low or falling volume and make sure to keep an eye on the stock. During the last day, the stock moved HK$0.0050 between high and low, or 0.143%. For the last week the stock has had daily average volatility of 4.46%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (2563.HK) For The Upcoming Trading Day Of Wednesday 12th

For the upcoming trading day on Wednesday, 12th we expect Beijing Biostar Pharmaceuticals Co., Ltd. to open at HK$3.50, and during the day (based on 14 day Average True Range), to move between HK$3.43 and HK$3.57, which gives a possible trading interval of +/-HK$0.132 (+/-3.84%) up or down from last closing price. If Beijing Biostar Pharmaceuticals Co., Ltd. takes out the full calculated possible swing range there will be an estimated 3.84% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at HK$3.39 (3.14%) than the resistance at HK$3.67 (4.86%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Beijing Biostar Pharmaceuticals Co., Ltd. stock A Buy?

Beijing Biostar Pharmaceuticals Co., holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.987 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 12, 2026 - HK$3.50 ( 0.0476%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

2563.HK Performance

Trading levels for 2563.HK

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 3.51 0.190%
R2 3.50 0.136%
R1 3.50 0.102%
Price 3.50
S1 3.50 -0.0070%
S2 3.50 -0.0407%
S3 3.50 -0.0952%

Accumulated Volume Support & Resistance Levels

Level Price
R3 4.20 20.00%
R2 3.70 5.71%
R1 3.67 4.86%
Price 3.50
S1 3.39 -3.14%
S2 3.21 -8.29%
S3 3.20 -8.57%

FAQ

What is the symbol for Beijing Biostar Pharmaceuticals Co., Ltd. Stock and on which exchange is it traded?
The symbol for Beijing Biostar Pharmaceuticals Co., Ltd. is 2563.HK and it is traded on the HKEX (Hong Kong Stock Exchange).

Should I buy or sell Beijing Biostar Pharmaceuticals Co., Ltd. Stock?
Based on market data through Aug 11, 2026, StockInvest.us rates Beijing Biostar Pharmaceuticals Co., Ltd. (2563.HK) as a Sell Candidate with a technical score of -3.99 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Sell signal began on Aug 04, 2026, the price has remained flat. The current 3-month trend forecast projects a fall of 17.22%.

How to buy Beijing Biostar Pharmaceuticals Co., Ltd. Stock?
Beijing Biostar Pharmaceuticals Co., Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Beijing Biostar Pharmaceuticals Co., Ltd. Stock.

What's the current price of Beijing Biostar Pharmaceuticals Co., Ltd. Stock?
As of the end of day on the Aug 11, 2026, the price of an Beijing Biostar Pharmaceuticals Co., Ltd. (2563.HK) share was HK$3.50.

What is the 52-week high and low for Beijing Biostar Pharmaceuticals Co., Ltd. Stock?
The 52-week high for Beijing Biostar Pharmaceuticals Co., Ltd. Stock is HK$9.63 and the 52-week low is HK$2.40.

What is the market capitalization of Beijing Biostar Pharmaceuticals Co., Ltd. Stock?
As of the Aug 11, 2026, the market capitalization of Beijing Biostar Pharmaceuticals Co., Ltd. is 846.023M.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE